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was completely inhibited. Under the same experimental condi- 
tions, changes in the total release of G2 domain measured by the 
G2 assay showed a different profile. There was an initial increase 
between days 2 and 5 followed by a progressive decline reaching 
detection limit by day 12 (Fig. 1 ). The addition of GM6001 did not 
have any influence on the course of this curve. 
Conclusion: These results suggest that the herein introduced 
sandwich immuno-assays G2 and FFGVG-G2 allow the assess- 
ment of separate processes of aggrecan metabolism in articular 
cartilage. Whereas the monitoring of FFGVG-G2 reflect aggrecan 
degradation, further studies are needed to clarify which aspects 
of aggrecan turnover are reflected by the changes in the total re- 
lease of the G2 domain from the explant cultures. The herein pre- 
sented assays carry noteworthy potentials to become useful tools 
for monitoring disease processes and the effects of interventions. 
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SIMULTANEOUS MEASUREMENT OF CELL AND MATRIX 
TURNOVER IN EXPERIMENTAL MODELS OF CARTILAGE 
DEGENERATION 
KW Li, SM Turner 
IR&D, KineMed, Inc, Emeryville, CA 
While a homeostatic balance between matrix synthesis and 
degradation is maintained in healthy cartilage, metabolic pro- 
cesses are modulated in osteoarthritis to favor catabolism. In this 
study, a novel biochemical method for measuring aspects of cell 
and matrix turnover using a single stable isotope precursor was 
validated and used to profile metabolic changes in animal and 
tissue culture models of cartilage degeneration. 
Bovine cartilage explants were maintained with medium including 
I L-1. For in vivo studies, degeneration was induced in rat knees by 
either chemical (monoiodoacetate) or mechanical (meniscal tear) 
interventions. Cartilage degeneration was confirmed by quantify- 
ing the release of sulfated GAG into culture medium or by his- 
tological analysis. To label newly-synthesized metabolites, 2H20 
was administered via either culture medium or drinking water. 
After isolation of DNA and chondroitin sulfate (CS) from carti- 
lage samples, the 2 H enrichments were quantified by GC/MS and 
used to calculate fractional de novo synthesis. 
Cartilage explants analyzed after 5 days in serum-supplemented 
culture had fractional CS synthesis of 134-2% (2.64-0.4%/day; 
n=4). This was comparable to the rate at which GAG was re- 
leased into the medium (2.3%/day). The inclusion of IL-1 inhibited 
the rate of CS turnover dose-dependently (Fig. 1A). Chondrocyte 
turnover (1.14-0.5%/day; n=16) also was inhibited by IL-1 (Fig. 
1B). 
MIA-treated rat knees developed regions of cartilage matrix loss 
and decreased cell viability 5 days after injection, and the de- 
generation progressively worsened. However, CS turnover in the 
cartilage from the affected knee remained indistinguishable from 
control knees until 9 days post-injection (Fig. 2). Rat knees in 
which the medial meniscus was torn exhibited gross degenera- 
tive changes earlier, within 3 days of surgery. CS synthesis was 
elevated with the onset of cartilage degeneration (day 3) relative 
to control knees, returning to control levels by day 9 (Fig. 3). In 
both forms of experimental OA, the degenerating cartilage exhib- 
ited a period of marked stimulation in CS turnover (~2X of con- 
trol), but this increase occurred on different timecourses. While 
the physiological implication of this is as yet unclear, it is evident 
that changes in CS synthesis rates are detectable in vivo and are 
modulated in both physical and chemical models of OA. 
This stable isotope/mass pectrometry approach can be used to 
measure turnover of other matrix constituents. Preliminary mea- 
surements indicate that in normal rat cartilage, collagen turns 
over at a rate of 1-3%/day. Thus, the method is robust, allowing 
multiple, simultaneous measurements from a single specimen of 
cartilage. The ability to evaluate cell-mediated alterations during 
OA progression in vitroand in vivois appealing in small animal ex- 
perimentation but may also have significant clinical applications. 
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THE TYPE II COLLAGEN DEGRADATION MARKERS 
HELIX II AND CTX-II, HAVE DISTINCT DISTRIBUTIONS IN 
TISSUE SECTIONS OF HUMAN ARTICULAR CARTILAGE, 
AND ARE AFFECTED DIFFERENTLY BY MENOPAUSE 
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Introduction: Helix-II and CTX-II are type II collagen degradation 
markers recognizing specific sequences from the helical and C- 
telopeptide domains of type II collagen, respectively. Both mak- 
ers are elevated in urine of patients with osteoarthritis (OA) or 
rheumatoid arthritis (RA). However, in these clinical conditions, 
Helix-II and CTX-II correlate only moderately with each other, 
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suggesting that they reflect o some extent, distinct biological pro- 
cesses. 
Aim: to investigate whether Helix-II and CTX-II reflect distinct 
degradation mechanisms, prevailing differently in distinct areas of 
cartilage, and varying differently with age and menopausal status 
in healthy subjects. 
Methods: Immunohistochemistry was performed on full depth 
knee cartilage biopsies obtained from OA patients, and the tis- 
sue distribution of Helix-II and CTX-II immunoreactivitywas deter- 
mined. Urinary Helix-II and CTX-II were measured in 105 healthy 
women (from 26 to 90 years, mean: 59 years) and 48 healthy men 
(from 26 to 79 years, mean: 48 years). 
Results: Immunoreactivity for Helix-II, but not for CTX-II, was 
associated with the matrix of fibrillated articular surfaces. Adja- 
cent non-fibrillated surfaces were negative. Immunoreactivity for 
CTX-II, but not for Helix-II, was associated with matrix close to 
bone outgrowths into cartilage, often in areas of calcified carti- 
lage. Urinary levels of Helix-II did not change significantly with 
age or menopausal status in healthy women. Urinary levels of 
CTX-II were stable in healthy premenopausal women from age 35 
to menopause, but in contrast to Helix-II, increased markedly by 
an average of 70% (p<0.0001) after the menopause and then in- 
creased slightly but not significantly with age in postmenopausal 
women. In healthy men, there was no significant change with age 
both for urinary Helix-II and CTX-II. 
Conclusion: These differences in cartilage tissue distribution 
and relative urinary levels of Helix-II and CTX-II (i) support the 
existence of distinct mechanism of type II collagen breakdown 
during cartilage degradation; (ii) show that the prevailing break- 
down mechanism varies with the region of cartilage; and (iii) show 
that these mechanisms differ in their susceptibilities to age and 
menopause. Helix-II and CTX-II may provide distinct and com- 
plementary information on cartilage turnover. 
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INHIBITION OF TYPE II COLLAGEN DEGRADATION IN 
THE OVARIECTOMIZED RAT BY ESTROGEN AND A 
SELECTIVE ESTROGEN RECEPTOR MODULATOR: 
CORRELATION BETWEEN TYPE II COLLAGEN 
BIOMARKERS 
PG Mitchel!, MG Chambers, C Lin, D Cummins, HW Cole, RL 
Cain, L Ma, MJ Berna, CA Schmalz, BL Ackermann, KL Duffin, 
JA Dodge, HU Bryant 
Musculoskeletal Division, Eli Lilly and Company, Indianapolis, IN 
Aim of Study: To determine the effect of estrogen and a 
SERM (LY505960) on the type II collagen biomarkers CTX-II and 
NET2C, in the rat ovariectomy (ovx) model and to investigate cor- 
relations between these two biomarkers. 
Methods: Forty-two 6-month-old female virgin Sprague Daw- 
ley rats underwent ovx and an additional 6 animals were sub- 
jected to sham ovx. Daily dosing began on day four post-ovx 
and consisted of the following eight groups (six animals/group): 
sham/vehicle, ovx/vehicle, ovx/17a-estradiol @ 0.01 and 0.10 
mg/kg, ovx/LY505960 @ 0.01, 0.10, 1.0 and 10.0 mg/kg. Prior 
to sacrifice (32 days post-ovx), overnight urines were collected. 
Urine samples from each animal were analyzed for type II col- 
lagen fragments containing the C-terminal telopeptide-derived 
peptide EKGPDP (CTX-II, Cartilaps: Nordic Bioscience Diagnos- 
tics A/S) by competition ELISA. The assay for a type II colla- 
gen neoepitope (NET2C) utilized online immunoaffinity capture 
with an antibody (9A4) specific for the collagenase-generated C- 
terminal neoepitope, followed by LC/MS/MS to quantify a spe- 
cific 14 mer collagen peptide (DGPSGSDGPPGPQG). CTX-II 
and NET2C concentrations in urine were normalized to creatinine 
levels. 
The data for each analyte were converted into pmoles/mole of 
creatinine and a Box-Cox transformation carried out in order to 
stabilize variances between groups to comply with standard sta- 
tistical ANOVA assumptions. A comparison of means was per- 
formed on the transformed ata using Dunnett's test for compar- 
ing each group to the non-dosed ovx group. 
Results: At 32 days post-ovx the CTX-II concentrations had in- 
creased 4.5 fold in the ovx animals while NET2C levels had in- 
creased 3.3 fold, compared with the sham-ovx animals (p<0.01). 
In comparison to the untreated ovx animals, both doses of 17a- 
estradiol and all doses of LY505960 significantly reduced both 
CTX-II levels and NET2C levels (p<0.01). A correlation coeffi- 
cient of 0.889 (regression R 2 = 0.7904) was obtained when the 
day 32 creatinine-adjusted values of CTX-II and NET2C values 
were plotted against each other. There was a small but statis- 
tically significant (p=0.0003) shift in the linear regression rela- 
tionship (CTX-II intercept at 0.69) and, a matched pairs analysis 
demonstrated that every treatment group except the sham-ovx 
group had higher CTX-II than NET2C values. 
Conclusions: We have extended previous reports relating 
to CTX-II in the ovx model, to demonstrate that NET2C, a 
collagenase-derived C-terminal type II collagen neoepitope, is el- 
evated in ovx rats and is sensitive to treatment with either estro- 
gen or the SERM, LY505960. Experimentally, a good correlation 
between CTX-II and NET2C was observed suggesting that re- 
lease of these two-type II collagen epitopes are temporally and 
mechanistically linked. The robust inhibition of type II collagen 
degradation by LY505960 in the rat ovx model suggests that this 
compound may be evaluated for treating osteoarthritis in post- 
menopausal women. 
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ADAMTS-7 DEGRADES COMP IN A Zn 2 +- AND 
pH-DEPENDENT MANNER AND IS SIGNIFICANTLY 
UPREGULATED IN THE CARTILAGE AND SYNOVlUM OF 
PATIENTS WITH RHEUMATOID ARTHRITIS 
C Liu, K Ilalov, B Sehgal, PE Di Cesare 
Orthopaedic Surgery, NYU-Hospital for Joint Diseases, New 
York, NY 
Study aims: Our genetic screen led to the discovery of ADAMTS- 
7 as an COMP-binding protein and ADAMTS-7 binds to the EGF 
domain of COMP via its C-terminal four TSP motifs. The purpose 
of this study was to characterize the mechanism underlying the 
ADAMTS-7-mediated COMP degradation and determine whether 
ADAMTS-7 expression was altered in the arthritic onditions. 
Methods: In vitro digestion assay: purified COMP (250nM) was 
incubated with recombinant ADAMTS-7 (25nM) in buffer (50mM 
Tris-HCI, 100mM NaCI, pH 7.5) supplemented with 5mM CaCI2, 
2mM ZnCL2, 2.5mM MgCI2, or various combinations at 37°C for 
12 hr. The digested proteins were visualized with Coomassie Blue 
R250. The same digestion was also performed at various pH val- 
ues. 
Subjects: Normal cartilage and synovium were obtained from 
the knees of four patients who died of diseases unrelated to 
arthritis. OA cartilage was obtained from the distal femora of 8 
patients and RA cartilage and synovium from the knees of 4 
RA patients. Expression of ADAMTS-7 in arthritic tissues: Real- 
time PCR was performed using a sequence-specific probe and 
primers for ADAMTS-7. 18s rRNA was used as internal control. 
PCR reactions were performed with 5 ng of cDNA, 100 nM probe, 
200 nM each primer, and 10.0 i~1 of TaqMan Universal 2' PCR 
Master Mix in a 20-1d reaction volume. 
Results: Zn 2+ is essential for the cleavage of COMP by 
ADAMTS-7- A degraded COMP fragment was detectable in the 
digestion buffer with Zn 2 +but was undetectable in the digestion 
buffer with Ca 2 + or Mg 2 + used alone. In the presence of Zn 2 +, 
the addition of Ca 2 +, but not Mg 2 +changed the electrophoretic 
